Artigo Acesso aberto

Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 — COVID-NET, 13 States, March 1–August 22, 2020

2020; Centers for Disease Control and Prevention; Volume: 69; Issue: 38 Linguagem: Inglês

10.15585/mmwr.mm6938e1

ISSN

1545-861X

Autores

Miranda J. Delahoy, Michael Whitaker, Alissa O’Halloran, Shua J. Chai, Pam Daily Kirley, Nisha B. Alden, Breanna Kawasaki, James Meek, Kimberly Yousey‐Hindes, Evan J. Anderson, Kyle P. Openo, Maya Monroe, Patricia Ryan, Kimberly Fox, Sue Kim, Ruth Lynfield, Samantha Siebman, Sarah Shrum Davis, Daniel M. Sosin, Grant Barney, Alison Muse, Nancy M. Bennett, Christina B. Felsen, Laurie M. Billing, Jessica Shiltz, Melissa Sutton, Nicole West, William Schaffner, H. Keipp Talbot, Andrea L. George, Melanie Spencer, Sascha Ellington, Romeo R. Galang, Suzanne M. Gilboa, Van T. Tong, Alexandra M. Piasecki, Lynnette Brammer, Alicia M. Fry, Aron J. Hall, Jonathan M. Wortham, Lindsay Kim, Shikha Garg, Mirasol Apostol, Susan Brooks, Ashley Coates, Linda Frank, Brooke Heidenga, Kareena Hundal, Joelle Nadle, Sherry Quach, Jeremy Roland, María Rosales, Isaac Armistead, Rachel Herlihy, Sarah McLafferty, Adam Misiorski, Christina Parisi, Danyel Olson, Carol A. Lyons, Amber Maslar, Paula Clogher, David Blythe, Alicia Brooks, Rachel Park, Michelle Wilson, Erica Bye, Kathryn Como‐Sabetti, Richard Danila, Maureen Sullivan, Kathy M. Angeles, Melissa Christian, Nancy Eisenberg, Caroline Habrun, Emily Hancock, Sarah A. Khanlian, Meaghan Novi, Yadira Salazar-Sanchez, Elizabeth Dufort, Nancy Spina, Ama Owusu-Dommey, Tiffanie Markus, Ryan Chatelain, Laine McCullough, Jake Ortega, Andrea Price, Ashley Swain, Anita Kambhampati, Seth Meador,

Tópico(s)

Maternal and fetal healthcare

Resumo

Pregnant women might be at increased risk for severe coronavirus disease 2019 (COVID-19) (1,2). The COVID-19-Associated Hospitalization Surveillance Network (COVID-NET) (3) collects data on hospitalized pregnant women with laboratory-confirmed SARS-CoV-2, the virus that causes COVID-19; to date, such data have been limited. During March 1-August 22, 2020, approximately one in four hospitalized women aged 15-49 years with COVID-19 was pregnant. Among 598 hospitalized pregnant women with COVID-19, 54.5% were asymptomatic at admission. Among 272 pregnant women with COVID-19 who were symptomatic at hospital admission, 16.2% were admitted to an intensive care unit (ICU), and 8.5% required invasive mechanical ventilation. During COVID-19-associated hospitalizations, 448 of 458 (97.8%) completed pregnancies resulted in a live birth and 10 (2.2%) resulted in a pregnancy loss. Testing policies based on the presence of symptoms might miss COVID-19 infections during pregnancy. Surveillance of pregnant women with COVID-19, including those with asymptomatic infections, is important to understand the short- and long-term consequences of COVID-19 for mothers and newborns. Identifying COVID-19 in women during birth hospitalizations is important to guide preventive measures to protect pregnant women, parents, newborns, other patients, and hospital personnel. Pregnant women and health care providers should be made aware of the potential risks for severe COVID-19 illness, adverse pregnancy outcomes, and ways to prevent infection.

Referência(s)